1. Silencing LncRNA SCAMP1 Inhibits Cell Proliferation in Hepatocellular Carcinoma via Activation of p53 Signaling Pathway
- Author
-
Xiaochen Ma, Sun Xiangyang, Caixia Li, Kai Zhang, and Yang Xie
- Subjects
Text mining ,Cell growth ,business.industry ,P53 Signaling Pathway ,Hepatocellular carcinoma ,Cancer research ,medicine ,Gene silencing ,Biology ,medicine.disease ,business - Abstract
Background: Long noncoding RNA secretory carrier membrane protein 1 (SCAMP1) has been recently reported to be an oncogene in several cancers, including glioma and ovarian cancer. However, its clinical significance and functional role in hepatocellular carcinoma (HCC) remain unknown.Methods: The expression of SCAMP1 was determined in tissue samples and cell lines using quantitative reverse transcription PCR. The clinical significance of SCAMP1 in HCC was evaluated using chi-squared test, Kaplan-Meier survival, as well as univariate and multivariate analysis. Cell proliferation, cell cycle distribution and apoptosis were evaluated using CCK-8 assay, colony formation assay, Flow cytometry analysis. Related protein expression levels were measured by western blot analysis.Results: We found SCAMP1 expression levels were remarkably up-regulated in HCC tissues compared with that in matched adjacent tissues. Increased SCAMP1 expression was significantly correlated with large tumor size, advanced TNM stage and poor survival prognosis in HCC. Knockdown of SCAMP1 significantly inhibited cell proliferation, induced G0/G1 phase arrest and apoptosis in HepG2 and SNU-182 cells. More importantly, knockdown of SCAMP1 downregulated the expression levels of CDK4, Cyclin D1 and Bcl-2, while upregulated the expression levels of p21, p53 and Bax.Conclusions: In summary, our study clarified the oncogenic role of SCAMP1 in HCC, and provided a potential therapeutic target for HCC treatment.
- Published
- 2020